Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anand V. Kulkarni
Observed name:
Anand Kulkarni
Institution:
Asian Institute of Gastroenterology
Observed institution:
Asian Institute of Gastroenterology
ORCID:
0000-0002-1240-1675
Observed ORCID:
0000-0002-1240-1675
OpenAlex ID:
A5133944846
Recompensation in Patients With Alcohol-Related Liver Disease—A Multicenter Study
2026
·
Anand V. Kulkarni
, Madhumita Premkumar
, et al.
·
Gastro Hep Advances
·
8
PDF
Epidemiology, Predictors of Antimicrobial Resistance and Empiric Treatment Strategies for Spontaneous Bacterial Peritonitis in Cirrhosis: A Multicentre SBP ‐ INDIA Study
2026
·
Nipun Verma
, Rohit Mehtani
, et al.
·
Alimentary Pharmacology & Therapeutics
·
2
PDF
Blood-based non-invasive tests show comparable accuracy in MetALD and MASLD for MRE-defined advanced fibrosis
2026
·
Akash Roy
, Surabhi Jajodia
, et al.
·
BMC Gastroenterology
·
2
Genetics of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD) in the Indian Ethnicity: An Update
2026
·
Ravikanth Vishnubhotla
, Govardhan Bale
, et al.
·
Journal of Clinical and Experimental Hepatology
·
1
Implications of Liver Failure Cutoffs for Mortality Prediction in Hospitalized Cirrhosis Patients: A Multicentric Study
2026
·
Arun Valsan
, Karan Kumar
, et al.
·
Gastro Hep Advances
·
1
Prediction of incident overt hepatic encephalopathy using individual and composite measures of minimal hepatic encephalopathy: the PrO-MHE study
2026
·
Akash Roy
, Utkarsh Bhattad
, et al.
·
Annals of Hepatology
PDF
Genetics in Metabolic Dysfunction–Associated Steatotic Liver Disease: Not Beyond the Evidence but Building the Evidence
2026
·
Ravikanth Vishnubhotla
, Govardhan Bale
, et al.
·
Journal of Clinical and Experimental Hepatology
IDDF2026-ABS-0048 Exploring practices and attitudes towards stopping hepatocellular carcinoma surveillance: a multinational clinician survey with over 500 respondents
2026
·
Georgia Zeng
, Simone Strasser
, et al.
·
Gut
PDF
Peri-procedural antibiotics for infection prevention in transjugular intrahepatic portosystemic shunt and plug-assisted retrograde transvenous obliteration: a randomised trial
2026
·
Aashika Bhashyakarla
, Sathwika Pasam
, et al.
·
Singapore Medical Journal
WED-505 RAAS inhibitors reduces mortality in a real-world multicentre study of liver cirrhosis
2026
·
N Apoorva Sasikumar
, Margaret Teng
, et al.
·
Journal of Hepatology
WCN26-7719 IMMUNOSUPPRESSIVE THERAPY IN IgA NEPHROPATHY ASSOCIATED WITH CHRONIC LIVER DISEASE
2026
·
Venkat Praneeth Reddy Kalva
, Prathyusha Bollam
, et al.
·
Kidney International Reports
WCN26-7705 DECODING HEPATORENAL CROSS-TALK IN IgA NEPHROPATHY WITH CHRONIC LIVER DISEASE: QUANTITATIVE INSIGHTS FROM A CORRELATIVE STUDY
2026
·
Venkat Praneeth Reddy Kalva
, Prathyusha Bollam
, et al.
·
Kidney International Reports
PDF
Nor-ursodeoxycholic Acid for Metabolic Dysfunction-associated Steatotic Liver Disease: Is There Enough Evidence for Clinical Use? A Critique of a Phase III Trial and Regulatory Endorsement of the Drug
2026
·
Karan Kumar
, Vivek Saraswat
, et al.
·
Journal of Clinical and Experimental Hepatology
Point-of-care Ultrasound (POCUS)-Guided Pragmatic Fluid and Albumin Resuscitation and Hemodynamic Monitoring in Cirrhosis and Septic Shock
2026
·
Madhumita Premkumar
, Kamal Kajal
, et al.
·
Journal of Clinical and Experimental Hepatology
Show more works
View as search
Works count:
14
Citation count:
14
H-index:
2
I10-index:
Year
Topic
Type